Regenesome Inc.
PrivateLast Round
Pre Seed
Aug 1, 2025
Total Funding Raised
$880,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Regenesome Inc. operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Pre Seed round in August 2025.
Regenesome Inc. is a biotechnology company that develops anti-aging technology intended for supplements, foods and cosmetics that utilize exosomes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Space Technology, Fashion & Beauty
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Data as a Service, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regenesome Inc. Comparables
Compare Regenesome Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TIME TRAVELER Inc. | 76% | |
| Jung+ Longevity | 68% | |
| Elysium Health | 65% |
For institutional investors. Book with your work email.
Regenesome Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Aug 1, 2025 | ||||
| Debt | May 1, 2025 | ||||
| Pre Seed | Oct 21, 2024 |
For institutional investors. Book with your work email.
Regenesome Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Leave a Nest Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 11, 2026
Monthly visitors grew 167% MoM, reaching 1.1K.
- Jul 24, 2026
Monthly visitors increased 46% MoM.
For institutional investors. Book with your work email.
Regenesome Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Regenesome Inc.'s valuation, stock price, and market status.
Is Regenesome Inc. a public or private company?
Regenesome Inc. is a private company.
What is the current stock price of Regenesome Inc.?
Regenesome Inc. is a private company, so its shares have no public market price. Caplight tracks Regenesome Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Regenesome Inc. worth (valuation)?
Valuation information for Regenesome Inc. is not publicly available.
Can I buy Regenesome Inc. stock?
Regenesome Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Regenesome Inc.'s last funding round?
Regenesome Inc.'s most recent funding round was Pre Seed on August 1, 2025.
Who are the main investors in Regenesome Inc.?
Key investors in Regenesome Inc. include Leave a Nest Capital.
Will Regenesome Inc. IPO soon?
No public IPO plans have been announced for Regenesome Inc..
How can I track Regenesome Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Regenesome Inc.'s shares on secondary markets.